Delivery Order SPE2DB22D1017-SPE2DB25FG6LM
- Not listed
- The Defense Logistics Agency awarded a $3,292.56 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with an ultimate completion date of August 19, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under an open procurement process. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $54,608.70 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pen injectors on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's substantial Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $3,812.90 by the Defense Logistics Agency's Medical Supply Chain on August 15, 2025, with completion scheduled for August 18, 2025. The contract covers the supply of Zepbound 5 mg/0.5 mL pen injections and represents a non-competitive, competitively awarded delivery order under the company's existing Indefinite Delivery Contract with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $44,644.60 by the Defense Logistics Agency on September 23, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 24, 2025. The award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $18,369.17 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors with an ultimate completion date of October 21, 2025. The contract, which is not set-aside and was competitively awarded, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors, with a contract ceiling value of $4,575.52. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $12,539.80 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on July 31, 2025. This firm fixed-price, competitively awarded delivery order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 1, 2025. The contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. The contract utilizes firm fixed pricing with no set-aside designation and is expected to be completed by May 5, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $46,091.55 for Zepbound 5 mg/0.5 ml pens on June 30, 2025, with an ultimate completion date of July 1, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction executed through AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $6,921.52 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract, designated as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG6LMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,507.77 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on July 2, 2025, with a completion date of July 3, 2025. The contract employs firm fixed pricing and was competitively awarded with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant portfolio of federal medical procurement contracts with the Defense Logistics Agency and related defense health entities. As a critical vendor for military and veteran healthcare systems, the company supplies an extensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The award of this Zepbound delivery order demonstrates the company's continued capability to meet federal procurement requirements through open competition and reflects its role as a key supplier within the DLA's pharmaceutical supply chain supporting Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.5k | 7/2/25 |